FDA Reveals Gender-Based Double Standard in Big Pharma Research
Quick poll: Anyone take prescription drugs? Okay, while we count the waving sea of raised arms out there in PR land, the FDA will thank you. Now, for you women out there in that sea, guess what? Big Pharma research is sexist.
No, really. And the FDA just proved it.
A recent study by the U.S. Food and Drug Administration proves that a gender-based double standard exists when it comes to tracking the side-effects of popular prescription drugs.
What was that song about bad medicine again?
The chart below shows us that men and women have very different reactions to certain meds:
Here’s the male side (and the top side-effect has us a little worried):
As the data shows, there are more than 2 million reaction records for women compared to less than 1.3
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in